INVESTMENTS

Chromologics has successfully completed its seed round financing. On top of Vækstfonden’s investment, the company received an additional €4M from Blue Horizon Ventures, Novo Seeds, Nordic Food Tech, and angel investor Giampaolo Cagnin for a total of €6M. The new investment not only strengthens the company’s initial strategic vision but also allows Chromologics to explore and expand their pipeline to address other market segments.

​

Chromologics is developing a bio-based portfolio of natural colorants via a fungal biotech platform for the food market,

tapping into a € 4.6B market opportunity.

About

Chromologics
Chromologics is a Danish biotech company established in 2017 and based in Copenhagen. Chromologics’ mission is to build a new foundation for best-in-class color solutions. The company’s proprietary technology of precision fermentation produces pigments with superior stability, dependable sourcing, and exceptional performance without the need for arable land, making it far more sustainable than other natural colorants. Chromologics’ vision is to become a global leader in fermentation-based, high-performance food colorants, setting a new standard for the industry. This scalable approach ensures consistent quality, reliable supply, and competitive pricing, addressing key challenges faced by food and beverage manufacturers. The first product, Natu.Red®, is compatible with most dietary needs, including kosher, halal, and vegan diets.

​

The Founders

The company was co-founded by Gerit Tolborg (CEO) and Anders Ødum (CTO), who met at the Technical University of Denmark (DTU) where they were both pursuing academic careers. Gerit’s PhD research led to the discovery of a novel group of fungal pigments, inspiring her and Anders to commercialize this breakthrough and found Chromologics, being the first movers in introducing lab-grown food colorants to the market. Financed by several soft money grants from the Novo Nordisk Foundation and the Innovation Foundation Denmark, Gerit and Anders matured the technology of Chromologics to attract international venture capital.